The DOI matches its Crossref record.
Increased p53 Protein Associated with Aging in Human Diploid Fibroblasts
Abstract
Molecular changes associated with cellular aging in a strain of human diploid fibroblasts, IMR-90, were addressed by analyzing the expression of the tumor suppressor protein, p53. In all studies, IMR-90 cultures were characterized as "young" or "near-senescent" based on morphology, rate of population doubling, capacity for DNA synthesis, and presence of established markers for senescence. When p53 was immunoprecipitated by monoclonal antibodies and detected by Western immunoblot analysis, more protein per cell was detected in the near-senescent cultures. A greater than 10-fold increase in p53 protein was measured with the PAb 1801 (N-terminal-specific) anti-p53 antibody, whereas PAb 122 (C-terminal-specific) measured a 5-fold increase. Although near-senescent cultures demonstrated a higher level of p53 than young cells, these cultures had similar charges and molecular weight p53 isoforms when analyzed by two-dimensional Western blots. When p53 RNA was compared to total RNA there was a decrease in p53 RNA with age, but on a per cell basis p53 RNA was elevated. These results provide evidence for transcriptional regulation of p53 during aging and support the hypothesis that elevated levels of p53 protein may play a role in cellular senescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the cell senescence process, two main proteins, a tumor suppressor protein and critical cell cycle regulator Retinoblastoma protein (Rb) and p53 tumor suppressor protein are activated; their inactivation prevented senescence (Kulju and Lehman 1995).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Kulju and Lehman 1995
Citations
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
The signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046
“The p53 protein is stabilized and proceeds to activate its transcriptional targets, such as p21CIP1/WAF1 (Kulju & Lehman, 1995).”
BackgroundKregel, K. C., & Zhang, H. J. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00327.2006 · Cited by 883
“Evidence has shown that both p53 and Rb protein are activated when cells are in a senescent state (131, 182), while inactivation of these two proteins prevents senescence of human lung fibroblasts (280) and allows senescent cells to resume proliferation (81, 228).”
BackgroundSenescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826
“…and p21Cip1 is detected in a variety of senescent cells, and overexpression of telomerase leads to immortalization of human cells in culture (Kulju and Lehman 1995; Alcorta et al. 1996; Hara et al. 1996; Reznikoff et al. 1996; Shay and Bacchetti 1997; Bodnar et al. 1998; van Steensel et al.…”
BackgroundBypass of Senescence After Disruption of p21 CIP1/WAF1 Gene in Normal Diploid Human Fibroblasts
Brown, J. P., Wei, W., & Sedivy, J. M. (1997) · Science · doi:10.1126/science.277.5327.831 · Cited by 804
Metadata
- Authors
- Kulju, K. S., & Lehman, J. M.
- Affiliations
- Albany Medical College (US)
- ORCID
- Lehman, John M.
- Venue
- Experimental Cell Research
- Publisher
- Elsevier BV
- Published
- 1995-04
- Volume
- 217
- Issue
- 2
- Pages
- 336-345
- ISSN
- 0014-4827 (ISSN-L)
- OpenAlex
- W2062636398
- Cited by
- 155
- References
- 0
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 4 · 2022: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 3 · 2012: 8
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Cell Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-41608)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p53, cellular senescence, cellular aging, human diploid fibroblasts, IMR-90 cells, p53 protein levels, p53 isoforms, tumor suppressor proteins
- MeSH terms
- Cell Cycle, Cell Line, Diploidy, Fibroblasts, Humans, RNA, Messenger, Electrophoresis, Gel, Two-Dimensional, Tumor Suppressor Protein p53, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review